Cargando…
The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction
BACKGROUND: This study aimed to evaluate the markers of insulin resistance and adipokine status in patients with visceral obesity during hospitalization following myocardial infarction (MI) and assess the disturbances of carbohydrate metabolism present 1 year after MI onset. METHODS: 94 male patient...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794814/ https://www.ncbi.nlm.nih.gov/pubmed/26989445 http://dx.doi.org/10.1186/s13098-016-0136-6 |
_version_ | 1782421526316843008 |
---|---|
author | Barbarash, Olga Gruzdeva, Olga Uchasova, Evgenya Dyleva, Yulia Belik, Ekaterina Akbasheva, Olga Karetnikova, Victoria Kokov, Alexander |
author_facet | Barbarash, Olga Gruzdeva, Olga Uchasova, Evgenya Dyleva, Yulia Belik, Ekaterina Akbasheva, Olga Karetnikova, Victoria Kokov, Alexander |
author_sort | Barbarash, Olga |
collection | PubMed |
description | BACKGROUND: This study aimed to evaluate the markers of insulin resistance and adipokine status in patients with visceral obesity during hospitalization following myocardial infarction (MI) and assess the disturbances of carbohydrate metabolism present 1 year after MI onset. METHODS: 94 male patients with MI were recruited. The exclusion criteria were as follows: age less than 50 or greater than 80 years, the presence of type 2 diabetes mellitus (T2DM), and a prior history of pronounced renal failure.Obesity types were defined according to body mass index (BMI), waist circumference (WC) and visceral adipose tissue (VAT) area. Glucose, insulin, adiponectin, leptin, and insulin resistance (IR) index were measured on days 1 and 12 after the onset of MI. New-onset type 2 diabetes was assessed 1 year after MI onset. RESULTS: According to computed tomography assessments of all study patients, 69 % of patients with MI suffered from visceral obesity. The VAT area was more closely associated with the risk of developing type 2 diabetes compared with the obesity parameters, BMI and WC. Patients with a VAT area greater than 130 cm(2) had a 3.6-fold higher risk of developing type 2 diabetes. The presence of IR and hyperleptinemia increased the risk of developing diabetes in the post-MI period 3.5 and 3.7 times, respectively, in patients with visceral obesity compared with patients without visceral obesity. CONCLUSION: Visceral obesity is associated with IR, a 5.7-fold increase in leptin levels and a high risk of developing type 2 diabetes 1 year after MI onset. |
format | Online Article Text |
id | pubmed-4794814 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47948142016-03-17 The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction Barbarash, Olga Gruzdeva, Olga Uchasova, Evgenya Dyleva, Yulia Belik, Ekaterina Akbasheva, Olga Karetnikova, Victoria Kokov, Alexander Diabetol Metab Syndr Research BACKGROUND: This study aimed to evaluate the markers of insulin resistance and adipokine status in patients with visceral obesity during hospitalization following myocardial infarction (MI) and assess the disturbances of carbohydrate metabolism present 1 year after MI onset. METHODS: 94 male patients with MI were recruited. The exclusion criteria were as follows: age less than 50 or greater than 80 years, the presence of type 2 diabetes mellitus (T2DM), and a prior history of pronounced renal failure.Obesity types were defined according to body mass index (BMI), waist circumference (WC) and visceral adipose tissue (VAT) area. Glucose, insulin, adiponectin, leptin, and insulin resistance (IR) index were measured on days 1 and 12 after the onset of MI. New-onset type 2 diabetes was assessed 1 year after MI onset. RESULTS: According to computed tomography assessments of all study patients, 69 % of patients with MI suffered from visceral obesity. The VAT area was more closely associated with the risk of developing type 2 diabetes compared with the obesity parameters, BMI and WC. Patients with a VAT area greater than 130 cm(2) had a 3.6-fold higher risk of developing type 2 diabetes. The presence of IR and hyperleptinemia increased the risk of developing diabetes in the post-MI period 3.5 and 3.7 times, respectively, in patients with visceral obesity compared with patients without visceral obesity. CONCLUSION: Visceral obesity is associated with IR, a 5.7-fold increase in leptin levels and a high risk of developing type 2 diabetes 1 year after MI onset. BioMed Central 2016-03-17 /pmc/articles/PMC4794814/ /pubmed/26989445 http://dx.doi.org/10.1186/s13098-016-0136-6 Text en © Barbarash et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Barbarash, Olga Gruzdeva, Olga Uchasova, Evgenya Dyleva, Yulia Belik, Ekaterina Akbasheva, Olga Karetnikova, Victoria Kokov, Alexander The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction |
title | The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction |
title_full | The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction |
title_fullStr | The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction |
title_full_unstemmed | The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction |
title_short | The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction |
title_sort | role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794814/ https://www.ncbi.nlm.nih.gov/pubmed/26989445 http://dx.doi.org/10.1186/s13098-016-0136-6 |
work_keys_str_mv | AT barbarasholga theroleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction AT gruzdevaolga theroleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction AT uchasovaevgenya theroleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction AT dylevayulia theroleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction AT belikekaterina theroleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction AT akbashevaolga theroleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction AT karetnikovavictoria theroleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction AT kokovalexander theroleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction AT barbarasholga roleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction AT gruzdevaolga roleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction AT uchasovaevgenya roleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction AT dylevayulia roleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction AT belikekaterina roleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction AT akbashevaolga roleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction AT karetnikovavictoria roleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction AT kokovalexander roleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction |